Yong Xia

4.6k total citations · 3 hit papers
59 papers, 3.3k citations indexed

About

Yong Xia is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Yong Xia has authored 59 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 32 papers in Surgery and 21 papers in Epidemiology. Recurrent topics in Yong Xia's work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers) and Liver Disease Diagnosis and Treatment (14 papers). Yong Xia is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers) and Liver Disease Diagnosis and Treatment (14 papers). Yong Xia collaborates with scholars based in China, Hong Kong and United States. Yong Xia's co-authors include Feng Shen, Kui Wang, Mengchao Wu, Xuying Wan, Dong Wu, Jun Li, Zhenlin Yan, Wan Yee Lau, Lehua Shi and Guanghua Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Yong Xia

57 papers receiving 3.2k citations

Hit Papers

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma A... 2013 2026 2017 2021 2013 2015 2021 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Xia China 27 1.5k 1.4k 937 870 810 59 3.3k
Masaji Hashimoto Japan 26 1.3k 0.9× 1.1k 0.8× 953 1.0× 890 1.0× 531 0.7× 208 3.1k
Sven Arke Lang Germany 25 1.2k 0.8× 1.4k 1.0× 1.2k 1.2× 463 0.5× 331 0.4× 112 2.9k
David Cosgrove United States 31 963 0.6× 788 0.6× 1.1k 1.2× 633 0.7× 397 0.5× 80 2.8k
Kiyoshi Kajiyama Japan 28 1.4k 0.9× 1.3k 1.0× 1.0k 1.1× 580 0.7× 432 0.5× 107 2.8k
Alexander Yaw Fui Chung Singapore 33 1.2k 0.8× 1.1k 0.8× 1.4k 1.5× 851 1.0× 723 0.9× 134 3.4k
Peihong Wu China 31 836 0.6× 699 0.5× 953 1.0× 726 0.8× 448 0.6× 124 2.7k
Yukiyasu Okamura Japan 28 633 0.4× 1.7k 1.2× 2.3k 2.4× 1.2k 1.4× 726 0.9× 213 3.6k
Daisuke Ban Japan 27 782 0.5× 843 0.6× 1.2k 1.3× 623 0.7× 419 0.5× 125 2.3k
Zhenlin Yan China 20 714 0.5× 954 0.7× 697 0.7× 678 0.8× 346 0.4× 36 1.9k
Daniel M. Labow United States 27 1.2k 0.8× 1.8k 1.3× 1.2k 1.2× 878 1.0× 320 0.4× 102 3.1k

Countries citing papers authored by Yong Xia

Since Specialization
Citations

This map shows the geographic impact of Yong Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Xia more than expected).

Fields of papers citing papers by Yong Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Xia. The network helps show where Yong Xia may publish in the future.

Co-authorship network of co-authors of Yong Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Xia. A scholar is included among the top collaborators of Yong Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Xia. Yong Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yingzi, et al.. (2025). Thermal comfort and energy-saving retrofits: An empirical study in high-altitude regions. Case Studies in Thermal Engineering. 72. 106220–106220.
2.
Zong, Chen, Hui Xue, Yao Li, et al.. (2024). YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis. The Journal of Gene Medicine. 26(5). e3689–e3689. 4 indexed citations
3.
Wang, Jie, et al.. (2024). Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer. Cancer Reports. 7(2). e1952–e1952. 3 indexed citations
5.
Wang, Yizhou, Yali Wu, Shichao Zhang, et al.. (2023). Outcomes of Liver Cancer Patients Undergoing Elective Surgery after Recovering from Mild SARS-CoV-2 Omicron Infection: A Retrospective Cohort Study. Cancers. 15(17). 4254–4254. 4 indexed citations
6.
Liu, Jianwei, Yong Xia, Caixia Lü, et al.. (2023). The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion. The Oncologist. 28(11). e1043–e1051. 12 indexed citations
8.
Yang, Pinghua, Fei Teng, Yong Xia, et al.. (2022). Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks. Gastroenterology report. 11. goad035–goad035. 5 indexed citations
9.
Chen, Qinjunjie, Haibo Wang, Zheng Li, et al.. (2021). Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. Journal of Hepatology. 76(1). 135–147. 171 indexed citations breakdown →
11.
Chen, Qinjunjie, Yuzhen Gao, Hui Xue, et al.. (2020). Developing a selection-aided model to screen Cirrhotic Intrahepatic Cholangiocarcinoma for Hepatectomy. Journal of Cancer. 11(19). 5623–5634. 3 indexed citations
12.
Hong, Honghai, Yousheng Mo, Zhiheng Xu, et al.. (2020). Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD. Molecular Therapy — Nucleic Acids. 20. 140–154. 15 indexed citations
13.
Si, Anfeng, Jun Li, Zhishi Yang, et al.. (2019). Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 26(6). 1841–1850. 61 indexed citations
14.
Zou, Qifei, Ying Hou, Haibo Wang, et al.. (2018). Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. EBioMedicine. 31. 287–298. 41 indexed citations
15.
Yang, Pinghua, Anfeng Si, Jue Yang, et al.. (2018). A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion. Surgery. 165(4). 721–730. 71 indexed citations
16.
Lei, Zhengqing, Yong Xia, Anfeng Si, et al.. (2017). Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection. Journal of Hepatology. 68(4). 655–662. 30 indexed citations
17.
Li, Jun, Jian Zhou, Pinghua Yang, et al.. (2016). Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. European Journal of Cancer. 62. 86–95. 42 indexed citations
18.
Liu, Jian, Kui Wang, Zhenlin Yan, et al.. (2016). Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. PLoS ONE. 11(5). e0154767–e0154767. 44 indexed citations
19.
Vitale, Alessandro, Alessandro Cucchetti, Matteo Cescon, et al.. (2014). Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit. Journal of Hepatology. 60(6). 1165–1171. 46 indexed citations
20.
Xia, Yong, Tao Xi, Kui Wang, et al.. (2012). A Case-Control Study of Correlation between Preoperative Serum AFP and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy. Hepatogastroenterology. 59(119). 2248–54. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026